Literature DB >> 31877213

Beat pediatric ALL MRD: CD28 CAR T and transplant.

Marco Ruella1, Frederick L Locke2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31877213      PMCID: PMC6933292          DOI: 10.1182/blood.2019003821

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Authors:  Stephen J Schuster; Michael R Bishop; Constantine S Tam; Edmund K Waller; Peter Borchmann; Joseph P McGuirk; Ulrich Jäger; Samantha Jaglowski; Charalambos Andreadis; Jason R Westin; Isabelle Fleury; Veronika Bachanova; S Ronan Foley; P Joy Ho; Stephan Mielke; John M Magenau; Harald Holte; Serafino Pantano; Lida B Pacaud; Rakesh Awasthi; Jufen Chu; Özlem Anak; Gilles Salles; Richard T Maziarz
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

2.  Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

Authors:  Rebecca A Gardner; Olivia Finney; Colleen Annesley; Hannah Brakke; Corinne Summers; Kasey Leger; Marie Bleakley; Christopher Brown; Stephanie Mgebroff; Karen S Kelly-Spratt; Virginia Hoglund; Catherine Lindgren; Assaf P Oron; Daniel Li; Stanley R Riddell; Julie R Park; Michael C Jensen
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

3.  Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.

Authors:  Frederick L Locke; Armin Ghobadi; Caron A Jacobson; David B Miklos; Lazaros J Lekakis; Olalekan O Oluwole; Yi Lin; Ira Braunschweig; Brian T Hill; John M Timmerman; Abhinav Deol; Patrick M Reagan; Patrick Stiff; Ian W Flinn; Umar Farooq; Andre Goy; Peter A McSweeney; Javier Munoz; Tanya Siddiqi; Julio C Chavez; Alex F Herrera; Nancy L Bartlett; Jeffrey S Wiezorek; Lynn Navale; Allen Xue; Yizhou Jiang; Adrian Bot; John M Rossi; Jenny J Kim; William Y Go; Sattva S Neelapu
Journal:  Lancet Oncol       Date:  2018-12-02       Impact factor: 41.316

4.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Authors:  Daniel W Lee; James N Kochenderfer; Maryalice Stetler-Stevenson; Yongzhi K Cui; Cindy Delbrook; Steven A Feldman; Terry J Fry; Rimas Orentas; Marianna Sabatino; Nirali N Shah; Seth M Steinberg; Dave Stroncek; Nick Tschernia; Constance Yuan; Hua Zhang; Ling Zhang; Steven A Rosenberg; Alan S Wayne; Crystal L Mackall
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321

Review 5.  Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You.

Authors:  Marco Ruella; Carl H June
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952

6.  CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

Authors:  Cameron J Turtle; Laïla-Aïcha Hanafi; Carolina Berger; Theodore A Gooley; Sindhu Cherian; Michael Hudecek; Daniel Sommermeyer; Katherine Melville; Barbara Pender; Tanya M Budiarto; Emily Robinson; Natalia N Steevens; Colette Chaney; Lorinda Soma; Xueyan Chen; Cecilia Yeung; Brent Wood; Daniel Li; Jianhong Cao; Shelly Heimfeld; Michael C Jensen; Stanley R Riddell; David G Maloney
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

7.  Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.

Authors:  Jae H Park; Isabelle Rivière; Mithat Gonen; Xiuyan Wang; Brigitte Sénéchal; Kevin J Curran; Craig Sauter; Yongzeng Wang; Bianca Santomasso; Elena Mead; Mikhail Roshal; Peter Maslak; Marco Davila; Renier J Brentjens; Michel Sadelain
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

8.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

9.  Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.

Authors:  Kevin J Curran; Steven P Margossian; Nancy A Kernan; Lewis B Silverman; David A Williams; Neerav Shukla; Rachel Kobos; Christopher J Forlenza; Peter Steinherz; Susan Prockop; Farid Boulad; Barbara Spitzer; Maria I Cancio; Jaap Jan Boelens; Andrew L Kung; Yasmin Khakoo; Victoria Szenes; Jae H Park; Craig S Sauter; Glenn Heller; Xiuyan Wang; Brigitte Senechal; Richard J O'Reilly; Isabelle Riviere; Michel Sadelain; Renier J Brentjens
Journal:  Blood       Date:  2019-12-26       Impact factor: 22.113

  9 in total
  2 in total

1.  Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.

Authors:  Anqi Dai; Guido Ghilardi; Andrea Facciabene; Marcel R M van den Brink; Marco Ruella; Melody Smith; Kimberly V Amelsberg; Sean M Devlin; Raymone Pajarillo; John B Slingerland; Silvia Beghi; Pamela S Herrera; Paul Giardina; Annelie Clurman; Emmanuel Dwomoh; Gabriel Armijo; Antonio L C Gomes; Eric R Littmann; Jonas Schluter; Emily Fontana; Ying Taur; Jae H Park; Maria Lia Palomba; Elizabeth Halton; Josel Ruiz; Tania Jain; Martina Pennisi; Aishat Olaide Afuye; Miguel-Angel Perales; Craig W Freyer; Alfred Garfall; Shannon Gier; Sunita Nasta; Daniel Landsburg; James Gerson; Jakub Svoboda; Justin Cross; Elise A Chong; Sergio Giralt; Saar I Gill; Isabelle Riviere; David L Porter; Stephen J Schuster; Michel Sadelain; Noelle Frey; Renier J Brentjens; Carl H June; Eric G Pamer; Jonathan U Peled
Journal:  Nat Med       Date:  2022-03-14       Impact factor: 87.241

Review 2.  The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies.

Authors:  Andriy Zhylko; Magdalena Winiarska; Agnieszka Graczyk-Jarzynka
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.